Green Cross Medical Science Corporation

KOSDAQ:A142280 Stok Raporu

Piyasa değeri: ₩88.9b

Green Cross Medical Science Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Green Cross Medical Science has a total shareholder equity of ₩38.1B and total debt of ₩23.2B, which brings its debt-to-equity ratio to 60.8%. Its total assets and total liabilities are ₩95.4B and ₩57.3B respectively. Green Cross Medical Science's EBIT is ₩370.3M making its interest coverage ratio 0.1. It has cash and short-term investments of ₩6.5B.

Anahtar bilgiler

60.8%

Borç/özkaynak oranı

₩23.16b

Borç

Faiz karşılama oranı0.1x
Nakit₩6.47b
Eşitlik₩38.11b
Toplam yükümlülükler₩57.29b
Toplam varlıklar₩95.40b

Son finansal sağlık güncellemeleri

Recent updates

Is Green Cross Medical Science (KOSDAQ:142280) A Risky Investment?

Aug 30
Is Green Cross Medical Science (KOSDAQ:142280) A Risky Investment?

There's No Escaping Green Cross Medical Science Corporation's (KOSDAQ:142280) Muted Revenues Despite A 45% Share Price Rise

Aug 08
There's No Escaping Green Cross Medical Science Corporation's (KOSDAQ:142280) Muted Revenues Despite A 45% Share Price Rise

We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated

Mar 26
We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated

Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings

Mar 23
Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings

These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively

Feb 24
These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively

Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?

Jan 28
Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?

Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?

Jan 02
Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?

Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?

Dec 07
Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: A142280's short term assets (₩47.4B) do not cover its short term liabilities (₩49.3B).

Uzun Vadeli Yükümlülükler: A142280's short term assets (₩47.4B) exceed its long term liabilities (₩7.9B).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: A142280's net debt to equity ratio (43.8%) is considered high.

Borcun Azaltılması: A142280's debt to equity ratio has reduced from 606.6% to 60.8% over the past 5 years.

Borç Kapsamı: A142280's debt is not well covered by operating cash flow (16.2%).

Faiz Kapsamı: A142280's interest payments on its debt are not well covered by EBIT (0.1x coverage).


Bilanço


Sağlıklı şirketleri keşfedin